Results 201 to 210 of about 47,313 (242)

Incidence of Major Adverse Cardiovascular Events in Patients With Rheumatoid Arthritis Treated With JAK Inhibitors Compared With Biologic Disease‐Modifying Antirheumatic Drugs: Data From an International Collaboration of Registries

open access: yesArthritis &Rheumatology, EarlyView.
Objective Our objective was to assess the incidence of major adverse cardiovascular events (MACEs) in patients with rheumatoid arthritis (RA) treated with JAK inhibitors (JAKi), tumor necrosis factor inhibitors (TNFi), or biologic disease‐modifying antirheumatic drugs with other modes of action (bDMARD‐OMA) in a multicountry, real‐world population ...
Romain Aymon   +28 more
wiley   +1 more source

Efficacy and safety of dotinurad versus febuxostat for the treatment of gout: a randomised, multicentre, double‐blind, phase 3 trial in China

open access: yesArthritis &Rheumatology, Accepted Article.
Objectives Dotinurad is a selective urate reabsorption inhibitor that reduces serum urate levels. We compared the efficacy and safety of dotinurad with febuxostat in Chinese patients with gout. Methods This phase 3, multicentre, randomised, double‐blind, parallel‐group study randomly allocated (1:1) eligible patients with gout to receive oral dotinurad
Jia Sun   +19 more
wiley   +1 more source

First‐in‐human safety, tolerability, pharmacokinetics and pilot food‐effect study of the candidate antimalarial compound MMV367

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Abstract Aim To evaluate the safety, tolerability and pharmacokinetics in healthy participants of orally administered MMV367 (GSK3772701), a novel antimalarial interfering with Plasmodium falciparum acyl coenzyme A synthetase 10/11 function. Methods This first‐in‐human study enrolled 47 healthy male and female participants.
Andrea Kuemmerle   +13 more
wiley   +1 more source

External Fixation for Supracondylar Fracture in Children.

open access: bronze, 1999
Naoaki Kahara   +5 more
openalex   +2 more sources

Sacrificial strategy towards the formation of vascular‐like networks in volumetric tissue constructs

open access: yesBMEMat, EarlyView.
This mini‐review highlights the latest progress in the sacrificial template‐enabled creation of patent vascular‐like networks, which can be incorporated into volumetric tissue constructs. Such microchannel networks can provide an immediate supply of nutrition and O2 to those cells residing next to the channels.
Christian Buckley   +5 more
wiley   +1 more source

Localized EIS Data for Capacity and SOH Prediction With Neural Networks

open access: yesBattery Energy, EarlyView.
This study showed a higher accurate capacity and state of health predictions using solely the most correlated frequencies for a neural network model. Findings showed that the charge transfer region is essential for battery prognosis studies, reducing the time needed for battery characterization using impedance.
Hakeem Thomas   +2 more
wiley   +1 more source

External Fixation for Bennett's Fracture and Rolando's Fracture.

open access: bronze, 1999
Tatsuro Tanaka   +8 more
openalex   +2 more sources

Transfer Learning‐Based Data‐Fusion Model Framework for State of Health Estimation of Power Battery Packs

open access: yesBattery Energy, EarlyView.
To handle nonlinearity and feature coupling, a data‐driven aging model is proposed, employing dual Gaussian Process Regressions and transfer learning to enhance model efficiency and accuracy. Adaptive filtering refines the model by integrating aging features and output capacity, resulting in a closed‐loop data fusion framework for SOH estimation ...
Zhiqiang Lyu   +3 more
wiley   +1 more source

Minimizing batch‐to‐batch variability of a live virus vaccine by process analytical technologies

open access: yesBiotechnology Progress, EarlyView.
Abstract For bioprocesses producing live virus, such as enterovirus Coxsackievirus A21, viral titer (infectivity basis) decay rates can exceed 30% within a day. Consequently, harvest timing is paramount. To optimize titer at harvest, a continuous viral product titer model was generated to elucidate kinetics.
Katherine Forrester   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy